A preclinical paper (PMC11180715) showed 2dDR hydrogel stimulated hair regrowth in a mouse AGA model at 80-90% of the effect of minoxidil; a human trial, 'Topical 2-Deoxy-D-ribose Hydrogel Versus Minoxidil 5% Solution for Androgenetic Alopecia' (NCT07502976), has since been registered on ClinicalTrials.gov.
- Lab
- Phase 1
- Phase 2
- Phase 3
- Approved
Lab / animal stage
How it works
A naturally occurring sugar formulated into a topical alginate hydrogel; proposed to upregulate VEGF (a blood-vessel-growth signal) in scalp skin to stimulate hair follicles, similar in concept to how minoxidil and PRP are thought to work.
Results so far
Mouse model: increased hair follicle density, anagen:telogen ratio, follicle diameter, and vascularization, with effects described as comparable (80-90%) to minoxidil — this is animal data only, no human efficacy data yet.
What's next
Human trial (NCT07502976) appears newly registered; no results or completion date were verified in this research pass.
In India
No India-specific development identified.
Sources
- Journal paper ↗ (accessed 2026-10-17)
- Trial registry ↗ (accessed 2026-10-17)
What to do today: treatments in development aren't a reason to wait. Ask a dermatologist about the options that work now, such as minoxidil and, for men, finasteride.
Discussion
Share your experience or ask a question. New members' posts are reviewed before they appear.